MITO 16 MANGO OV2B
Trial Description:
A multicenter phase III randomized study with second line chemotherapy plus or minus bevacizumab in patients with platinum sensitive epithelial ovarian cancer recurrence after a bevacizumab/chemotherapy first line
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
spignata